Screener
Nuvation Bio NUVB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| For the Six Months Ended June 30, | 2026 | 2025 |
|---|---|---|
| Accounts payable | 3,110 | 16,071 |
| Contract liabilities | (1,737) | (4,505) |
| Accrued expenses | 1,453 | (8,835) |
| Net cash used in operating activities | (37,900) | (90,805) |
| Cash flow from investing activities: | ||
| Purchases of marketable securities | (149,840) | (142,378) |
| Proceeds from sale of marketable securities | 112,497 | 251,689 |
| Purchases of property and equipment | (302) | (253) |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's operating cash flow?
- Nuvation Bio (NUVB) reported operating cash flow of -$42.97M in Q2 2026.
- How has Nuvation Bio's operating cash flow changed year-over-year?
- Nuvation Bio's operating cash flow increased by 10.8% year-over-year, from -$48.18M to -$42.97M.
- What is the long-term trend for Nuvation Bio's operating cash flow?
- Over 4 years (2021 to 2025), Nuvation Bio's operating cash flow has grown at a 26.3% compound annual growth rate (CAGR), from -$68.19M to -$173.43M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Nuvation Bio's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude